BioLife Solutions Secures Strategic Customer Wins and Plans 2022 Expansion in $400 Million Biostorage Services Market

BOTHELL, Wash., March 15, 2022 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies (“CGT”) and broader biopharma markets, today provided additional details on its growth expectations…

About the Author

has written 41816 stories on this site.

Copyright © 2010 Business and Corporate News.